Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
Author Information
Author(s): Walenda Thomas, Bokermann Gudrun, Jost Edgar, Galm Oliver, Schellenberg Anne, Koch Carmen M., Piroth Daniela M., Drescher Wolf, Brümmendorf Tim H., Wagner Wolfgang
Primary Institution: RWTH Aachen University Medical School
Hypothesis
Are systemically released factors involved in the activation of hematopoietic stem and progenitor cells after autologous HSCT?
Conclusion
Serum taken during hematopoietic stress significantly enhances the proliferation and maintenance of primitive immunophenotype of hematopoietic progenitor cells.
Supporting Evidence
- Serum taken 8 days after HSCT significantly enhanced proliferation of HPC compared to serum taken before chemotherapy.
- Colony forming unit frequency was significantly increased with serum from neutropenic patients.
- Maintenance of CD34 expression in HPC was enhanced by serum taken during hematopoietic stress.
Takeaway
Doctors found that blood serum from patients after a stem cell transplant helps their stem cells grow and multiply better.
Methodology
Serum samples were taken from patients at various times around their HSCT and used to culture CD34+ cord blood hematopoietic progenitor cells to assess proliferation and maintenance of primitive function.
Potential Biases
Potential bias due to the small number of patients and the specific conditions under which serum samples were collected.
Limitations
The study primarily focused on a small sample size and specific patient conditions, which may limit the generalizability of the findings.
Participant Demographics
Patients included individuals with multiple myeloma and non-Hodgkin lymphoma, aged 21 to 64 years.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website